ArticleJournal of cancer research and clinical oncology2019

Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer.

Ji Hyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.